Back

Cardiovascular mortality cannot be decreased by antidiabetic drugs

28 August 2016 (09:37 - 10:00)
Organised by:
Congress Presentation Part of: Cardio-diabetology alliance - The myth busters Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Eberhard Standl

Forschergruppe Diabetes eV at Helmholtz Center Munich, Munich (Germany)

3 More presentations in this session

Presentation thumbnail
Metabolically healthy obese people will populate the earth
Professor D. Gaita (Timisoara, RO)
Slides Video
Presentation thumbnail
Metformin will remain the first option in oral treatment of diabetes
Professor N. Sattar (Glasgow, GB)
Slides Video
Presentation thumbnail
Beta-blockers and diuretics are not neutral for metabolism
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Cardio-diabetology alliance - The myth busters

The Event

Event poster

ESC Congress 2016

28 August 2016 09:37 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Glycated haemoglobin and the association with long-term survival among patients evaluated for stable angina - a prospective Norwegian cohort
28 August 2022
thumbnail
Webinar
Managing cardiovascular aspects in diabetes and metabolic syndrome patients
14 February 2022
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources